SF
Distinguished in Metastatic Brain Tumor
Check Dr. Scott R. Floyd's experience treating your condition:
About Dr. Scott R. Floyd

Scott Floyd is a Radiation Oncologist in Durham, North Carolina. Floyd has been practicing medicine for over 21 years and is rated as a Distinguished expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 13 other conditions, according to our data. His top areas of expertise are Brain Tumor, Glioma, Metastatic Brain Tumor, Glioblastoma, and Gamma Knife Radiosurgery. He is licensed to treat patients in Massachusetts. Floyd is currently accepting new patients.

His clinical research consists of co-authoring 40 peer reviewed articles and participating in 4 clinical trials in the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Scott R. Floyd it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
2301 Erwin Rd, Durham, NC 27705
Other Locations
20 Duke Medicine Cir, Durham, NC 27710
Background & Education
Graduate Institution
Yale University School Of Medicine, 2002
Specialties
Radiation Oncology
Licenses
Radiology in MA
Hospital Affiliations
Duke Regional Hospital
Duke University Hospital
Duke Raleigh Hospital
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Quantitative MR Imaging Methods for Functional Assessment Following Stereotactic Body Radiation Therapy for Spinal Metastases
A Randomized, Phase II Trial of SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer
View 1 Less Clinical Trial -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Distinguished
Distinguished